Zohaib Yousaf
Research Subjects
Zohaib Yousaf has a total of 321 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Junaid Tahir
Department of Radiology, Research Centre, Shaukat Khanam Memorial Cancer Hospital, Lahore, Pakistan
23 shared publications - Muhammad Sohaib Asghar
AdventHealth Sebring Sebring Florida USA
15 shared publications - Fateen Ata
Cleveland Clinic Foundation Ohio USA
11 shared publications - Irfan Ullah
Department of Internal Medicine Khyber Teaching Hospital Peshawar Pakistan
9 shared publications - Khabab Abbasher Hussien Mohamed Ahmed
Faculty of Medicine University of Khartoum Khartoum Sudan
6 shared publications - Waleed Tariq
Department of Thoracic Surgery, Mayo Hospital, Lahore, Pakistan
6 shared publications
Latest Publications
- Open Access
- 6 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (23) , e42806
Knowledge, attitude, and perception of Pakistani women regarding breast cancer and mammography screening: A cross-sectional study
Breast cancer is one of the most common cancers in females. In low- and middle-income countries like Pakistan, reported incidence and prevalence remain unreliable. The aim was to evaluate Pakistani women’s knowledge, attitude, and perception of breast cancer. This cross-sectional study was conducted among Pakistani women from Punjab, Pakistan. A self-administered online questionnaire was formulated to collect data from the participants from September 24, 2022, to October 24, 2022. The questionnaire included sociodemographic data, knowledge questions regarding breast cancer risk factors, knowledge questions about symptoms of breast cancer, and questions assessing the participants’ attitudes toward mammography screening. For knowledge questions, a score of more than 7 out of 13 was considered good knowledge. For attitude questions, regression analysis was done and a score of more than 5 out of 11 was considered a positive attitude. Data was analyzed using SPSS version 25 (Chicago). 796 women participated in this study. Out of 796 participants, 543 (68.2%) were between 20 and 30 years of age, and 43 (5.4%) were more than 40 years old. The level of knowledge regarding breast cancer risk factors was suboptimal. 523 (65.7%) of the participants thought that breast cancer risk increases with advancing age and 218 (27.4%) thought that early menarche increases the risk of developing breast cancer. 471 (59.2%) mentioned that mammography is an effective tool for detecting breast cancer, and 30 (3.8%) thought that there is a cure for breast cancer. According to regression analysis, higher education, higher monthly household income, and married marital status were significantly associated with good knowledge related to breast cancer. Although most of the population is aware of breast cancer’s risk factors and symptoms, they avoid screening such as mammography. Public awareness projects could help increase women’s knowledge of breast cancer signs, symptoms, and screening.
- 6 June 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (23) , e42806
Open AccessKnowledge, attitude, and perception of Pakistani women regarding breast cancer and mammography screening: A cross-sectional study
Breast cancer is one of the most common cancers in females. In low- and middle-income countries like Pakistan, reported incidence and prevalence remain unreliable. The aim was to evaluate Pakistani women’s knowledge, attitude, and perception of breast cancer. This cross-sectional study was conducted among Pakistani women from Punjab, Pakistan. A self-administered online questionnaire was formulated to collect data from the participants from September 24, 2022, to October 24, 2022. The questionnaire included sociodemographic data, knowledge questions regarding breast cancer risk factors, knowledge questions about symptoms of breast cancer, and questions assessing the participants’ attitudes toward mammography screening. For knowledge questions, a score of more than 7 out of 13 was considered good knowledge. For attitude questions, regression analysis was done and a score of more than 5 out of 11 was considered a positive attitude. Data was analyzed using SPSS version 25 (Chicago). 796 women participated in this study. Out of 796 participants, 543 (68.2%) were between 20 and 30 years of age, and 43 (5.4%) were more than 40 years old. The level of knowledge regarding breast cancer risk factors was suboptimal. 523 (65.7%) of the participants thought that breast cancer risk increases with advancing age and 218 (27.4%) thought that early menarche increases the risk of developing breast cancer. 471 (59.2%) mentioned that mammography is an effective tool for detecting breast cancer, and 30 (3.8%) thought that there is a cure for breast cancer. According to regression analysis, higher education, higher monthly household income, and married marital status were significantly associated with good knowledge related to breast cancer. Although most of the population is aware of breast cancer’s risk factors and symptoms, they avoid screening such as mammography. Public awareness projects could help increase women’s knowledge of breast cancer signs, symptoms, and screening.
- Open Access
- 21 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (12) , e41892
Trends and disparities in the prevalence of diagnosed arthritis among United States adults from 2019 to 2022
Arthritis is a predominant cause of disability in the United States, imposing substantial economic burdens and public health challenges. This study aimed to analyze the trends and disparities in the prevalence of arthritis among US adults from 2019 to 2022. The National Health Interview Survey (NHIS) database of the Center for Disease Control and Prevention was analyzed, employing Joinpoint regression analysis for determining annual percentage changes (APCs) and prevalence percentages with 95% confidence intervals (CI). The prevalence of diagnosed arthritis among US adults remained relatively stable and slightly increased from 21.4% (95% CI: 20.9, 22.0) in 2019 to 21.6% (95% CI: 21.0, 22.2) in 2022 (APC: 0.4698; 95% CI: ‐1.0841, 2.0577). Females had a higher prevalence, which also increased from 24.3% to 25.0% (APC: 1.0218; 95% CI: ‐0.4408, 2.5223) with male prevalence ranging from 18.3% to 18.0% (APC: ‐0.3254; 95% CI: ‐2.6590, 2.0817). Age-related differences were particularly evident, with rates peaking in individuals aged ≥ 75 years at 53.9% in 2022. Racial disparities were observed, with White adults having a higher prevalence each year (23.8% in 2022). Geographic factors influenced prevalence, with higher rates noted in areas outside metropolitan areas and in the Midwest. Analysis of the NHIS database indicated a slight rise in arthritis prevalence overall, accompanied by notable demographic disparities. These results emphasize the necessity for tailored public health interventions and efficient disease management approaches tailored to specific populations.
- 21 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (12) , e41892
Open AccessTrends and disparities in the prevalence of diagnosed arthritis among United States adults from 2019 to 2022
Arthritis is a predominant cause of disability in the United States, imposing substantial economic burdens and public health challenges. This study aimed to analyze the trends and disparities in the prevalence of arthritis among US adults from 2019 to 2022. The National Health Interview Survey (NHIS) database of the Center for Disease Control and Prevention was analyzed, employing Joinpoint regression analysis for determining annual percentage changes (APCs) and prevalence percentages with 95% confidence intervals (CI). The prevalence of diagnosed arthritis among US adults remained relatively stable and slightly increased from 21.4% (95% CI: 20.9, 22.0) in 2019 to 21.6% (95% CI: 21.0, 22.2) in 2022 (APC: 0.4698; 95% CI: ‐1.0841, 2.0577). Females had a higher prevalence, which also increased from 24.3% to 25.0% (APC: 1.0218; 95% CI: ‐0.4408, 2.5223) with male prevalence ranging from 18.3% to 18.0% (APC: ‐0.3254; 95% CI: ‐2.6590, 2.0817). Age-related differences were particularly evident, with rates peaking in individuals aged ≥ 75 years at 53.9% in 2022. Racial disparities were observed, with White adults having a higher prevalence each year (23.8% in 2022). Geographic factors influenced prevalence, with higher rates noted in areas outside metropolitan areas and in the Midwest. Analysis of the NHIS database indicated a slight rise in arthritis prevalence overall, accompanied by notable demographic disparities. These results emphasize the necessity for tailored public health interventions and efficient disease management approaches tailored to specific populations.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA2104
Reducing pleural fluid mischaracterization – Using demographics to improve Light’s criteria.
Introduction: Light’s criteria has a high sensitivity (up to 98%) in detecting exudative pleural effusions but a specificity of 80%. Multiple predictive models in medicine use demographics, but Light’s criteria relies solely on laboratory parameters. We aimed to assess the association of demographics in characterizing pleural effusion. Methods: This is a retrospective study of 1,155 consecutive patients with pleural effusion who underwent a thoracentesis. SPSS 25.0 was used to analyze the data to calculate mean, median, univariate, and multivariable logistic regressions. We adjusted for confounders like age, race, sex, comorbidities, and type of effusion (parapneumonic). ROC curves were generated to calculate the diagnostic accuracy. Results: Age was the most significant factor associated with transudative effusion [Table 1]. Female gender [Adjusted OR: 2.071 (1.151-3.728), p=0.015] and Arab population [Adjusted OR: 3.015 (1.693-5.369), p<0.001] were strong predictors of transudative effusion even after adjusting for age, comorbidities and parapneumonic cause. CHF [Adjusted OR: 4.540 (1.840-11.200), p=0.001] and CKD [Adjusted OR: 2.994 (1.435-6.248), p=0.003] were associated with transudate. On ROC, pleural fluid LDH was found to have the highest diagnostic accuracy for diagnosing exudative effusion (91.9%), followed by pleural fluid protein (86.4%) and pleural fluid WBC (74.1%), while pleural fluid glucose had 90.5% accuracy for transudative effusion. Conclusion: Our study found an association between sociodemographic factors like age, gender, and race with the type of pleural effusion. Further, well-designed studies may improve the diagnostic accuracy of pleural fluid characterization.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA2104
Reducing pleural fluid mischaracterization – Using demographics to improve Light’s criteria.
Introduction: Light’s criteria has a high sensitivity (up to 98%) in detecting exudative pleural effusions but a specificity of 80%. Multiple predictive models in medicine use demographics, but Light’s criteria relies solely on laboratory parameters. We aimed to assess the association of demographics in characterizing pleural effusion. Methods: This is a retrospective study of 1,155 consecutive patients with pleural effusion who underwent a thoracentesis. SPSS 25.0 was used to analyze the data to calculate mean, median, univariate, and multivariable logistic regressions. We adjusted for confounders like age, race, sex, comorbidities, and type of effusion (parapneumonic). ROC curves were generated to calculate the diagnostic accuracy. Results: Age was the most significant factor associated with transudative effusion [Table 1]. Female gender [Adjusted OR: 2.071 (1.151-3.728), p=0.015] and Arab population [Adjusted OR: 3.015 (1.693-5.369), p<0.001] were strong predictors of transudative effusion even after adjusting for age, comorbidities and parapneumonic cause. CHF [Adjusted OR: 4.540 (1.840-11.200), p=0.001] and CKD [Adjusted OR: 2.994 (1.435-6.248), p=0.003] were associated with transudate. On ROC, pleural fluid LDH was found to have the highest diagnostic accuracy for diagnosing exudative effusion (91.9%), followed by pleural fluid protein (86.4%) and pleural fluid WBC (74.1%), while pleural fluid glucose had 90.5% accuracy for transudative effusion. Conclusion: Our study found an association between sociodemographic factors like age, gender, and race with the type of pleural effusion. Further, well-designed studies may improve the diagnostic accuracy of pleural fluid characterization.
- Open Access
- 26 July 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (10) , 4297-4301
Left superior vena cava's unconventional path to left atrium drainage: A case report
- 26 July 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (10) , 4297-4301
Open AccessLeft superior vena cava's unconventional path to left atrium drainage: A case report
- Open Access
- 17 May 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (7) , 3808-3811
Tele-stroke: a strategy to improve acute stroke care in low- and middle-income countries
- 17 May 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (7) , 3808-3811
Open AccessTele-stroke: a strategy to improve acute stroke care in low- and middle-income countries
- Open Access
- 10 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (45) , e35718
Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis
Background: Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker that is used to predict mortality, readmission, early discharge, and LOS, thus, serves as a useful tool for ED physicians. Our study aims to analyze the efficacy of suPAR in predicting these prognostic markers in ED. Methods: We performed a comprehensive search on 6 databases from the inception to 30th November 2022, to select the following eligibility criteria; a) observation or triage trial studies investigating the role of suPAR levels in predicting: 30 day and 90-day mortality, 30-day readmission, early discharge (within 24hr), and LOS in patients coming to AMU. Results: A total of 13 studies were included, with a population size of 35,178, of which 52.9% were female with a mean age of 62.93 years. Increased risk of 30-day mortality (RR = 10.52; 95% CI = 4.82–22.95; I2 = 38%; P < .00001), and risk of 90-day mortality (RR = 5.76; 95% CI = 3.35–9.91; I2 = 36%; P < .00001) was observed in high suPAR patients. However, a slightly increased risk was observed for 30-day readmission (RR = 1.50; 95% CI = 1.16–1.94; I2 = 54%; P = .002). More people were discharged within 24hr in the low suPAR level group compared to high suPAR group (RR = 0.46; 95% CI = 0.40–0.53; I2 = 41%; P < .00001). LOS was thrice as long in high suPAR level patients than in patients with low suPAR (WMD = 3.20; 95% CI = 1.84–4.56; I2 = 99%; P < .00001). Conclusion: suPAR is proven to be a significant marker in predicting 30-day and 90-day mortality in ED patients.
- 10 November 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (45) , e35718
Open AccessRole of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis
Background: Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker that is used to predict mortality, readmission, early discharge, and LOS, thus, serves as a useful tool for ED physicians. Our study aims to analyze the efficacy of suPAR in predicting these prognostic markers in ED. Methods: We performed a comprehensive search on 6 databases from the inception to 30th November 2022, to select the following eligibility criteria; a) observation or triage trial studies investigating the role of suPAR levels in predicting: 30 day and 90-day mortality, 30-day readmission, early discharge (within 24hr), and LOS in patients coming to AMU. Results: A total of 13 studies were included, with a population size of 35,178, of which 52.9% were female with a mean age of 62.93 years. Increased risk of 30-day mortality (RR = 10.52; 95% CI = 4.82–22.95; I2 = 38%; P < .00001), and risk of 90-day mortality (RR = 5.76; 95% CI = 3.35–9.91; I2 = 36%; P < .00001) was observed in high suPAR patients. However, a slightly increased risk was observed for 30-day readmission (RR = 1.50; 95% CI = 1.16–1.94; I2 = 54%; P = .002). More people were discharged within 24hr in the low suPAR level group compared to high suPAR group (RR = 0.46; 95% CI = 0.40–0.53; I2 = 41%; P < .00001). LOS was thrice as long in high suPAR level patients than in patients with low suPAR (WMD = 3.20; 95% CI = 1.84–4.56; I2 = 99%; P < .00001). Conclusion: suPAR is proven to be a significant marker in predicting 30-day and 90-day mortality in ED patients.
- 22 July 2023
- Published by Elsevier in Radiología (English Edition)
- Vol. 65 (4) , 385-386
The future role of forensic radiology — scope and challenges
- 22 July 2023
- Published by Elsevier in Radiología (English Edition)
- Vol. 65 (4) , 385-386
The future role of forensic radiology — scope and challenges
- 3 May 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 108 (5) , 942-947
Reporting of Azithromycin Activity against Clinical Isolates of Extensively Drug-Resistant Salmonella enterica Serovar Typhi
: This study aimed to evaluate the minimum inhibitory concentration (MIC) of azithromycin (AZM) in clinical isolates of extensively drug-resistant (XDR) Salmonella Typhi (i.e., resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole, fluoroquinolones, and third-generation cephalosporin) using the E-test versus the broth microdilution method (BMD). From January to June 2021, a retrospective cross-sectional study was carried out in Lahore, Pakistan. Antimicrobial susceptibility was performed initially by the Kirby-Bauer disk diffusion method for 150 XDR Salmonella enterica serovar Typhi isolates, and MICs of all the recommended antibiotics were determined by the VITEK 2 (BioMérieux) fully automated system using Clinical Laboratory Standard Institute (CLSI) 2021 guidelines. The E-test method was used to determine AZM MICs. These MICs were compared with the BMD, which is the method recommended by the CLSI but not adopted in routine laboratory reporting. Of 150 isolates, 10 (6.6%) were resistant by disk diffusion. Eight (5.3%) of these had high MICs against AZM by the E-test. Only three isolates (2%) were resistant by E-test, having an MIC of 32 μg/mL. All eight isolates had a high MIC by BMD with different MIC distributions, but only one was resistant, having an MIC of 32 μg/mL by BMD. The sensitivity, specificity, negative predictive value, positive predictive value, and diagnostic accuracy of the E-test method versus BMD were 98.65%,100%, 99.3%, 33.3%, and 98.6%, respectively. Similarly, the concordance rate was 98.6%, negative percent agreement was 100%, and positive percent agreement was 33%. The BMD is the most reliable approach for reporting AZM sensitivity in XDR S. Typhi compared with the E-test and disk diffusion methods. Potentially, AZM resistance in XDR S. Typhi is around the corner. Sensitivity patterns should be reported with MIC values, and if possible, higher values should be screened for the presence of any potential resistance genes. Antibiotic stewardship should be strictly implemented.
- 3 May 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 108 (5) , 942-947
Reporting of Azithromycin Activity against Clinical Isolates of Extensively Drug-Resistant Salmonella enterica Serovar Typhi
: This study aimed to evaluate the minimum inhibitory concentration (MIC) of azithromycin (AZM) in clinical isolates of extensively drug-resistant (XDR) Salmonella Typhi (i.e., resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole, fluoroquinolones, and third-generation cephalosporin) using the E-test versus the broth microdilution method (BMD). From January to June 2021, a retrospective cross-sectional study was carried out in Lahore, Pakistan. Antimicrobial susceptibility was performed initially by the Kirby-Bauer disk diffusion method for 150 XDR Salmonella enterica serovar Typhi isolates, and MICs of all the recommended antibiotics were determined by the VITEK 2 (BioMérieux) fully automated system using Clinical Laboratory Standard Institute (CLSI) 2021 guidelines. The E-test method was used to determine AZM MICs. These MICs were compared with the BMD, which is the method recommended by the CLSI but not adopted in routine laboratory reporting. Of 150 isolates, 10 (6.6%) were resistant by disk diffusion. Eight (5.3%) of these had high MICs against AZM by the E-test. Only three isolates (2%) were resistant by E-test, having an MIC of 32 μg/mL. All eight isolates had a high MIC by BMD with different MIC distributions, but only one was resistant, having an MIC of 32 μg/mL by BMD. The sensitivity, specificity, negative predictive value, positive predictive value, and diagnostic accuracy of the E-test method versus BMD were 98.65%,100%, 99.3%, 33.3%, and 98.6%, respectively. Similarly, the concordance rate was 98.6%, negative percent agreement was 100%, and positive percent agreement was 33%. The BMD is the most reliable approach for reporting AZM sensitivity in XDR S. Typhi compared with the E-test and disk diffusion methods. Potentially, AZM resistance in XDR S. Typhi is around the corner. Sensitivity patterns should be reported with MIC values, and if possible, higher values should be screened for the presence of any potential resistance genes. Antibiotic stewardship should be strictly implemented.
- 10 April 2023
- Published by Elsevier in Radiologia
- Vol. 65 (4) , 385-386
El papel de la radiología forense en el futuro: alcance y desafíos
- 10 April 2023
- Published by Elsevier in Radiologia
- Vol. 65 (4) , 385-386
El papel de la radiología forense en el futuro: alcance y desafíos